相关实验视频
Updated: Sep 14, 2025

05:39
Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
1.7K
甲状腺眼病的特鲁马布:机制,临床有效性和当前的挑战
Yuan Zong1,2,3,4, Shuang Qiu1, Mingming Yang2
1Department of Ophthalmology, Zhongshan Torch Development Zone People's Hospital, Zhongshan 528436, China.
Antibodies (Basel, Switzerland)
|July 23, 2025
概括
德鲁马布通过向IGF-1R/TSHR通路,减少proptosis和炎症,有效治疗甲状腺眼病 (TED). 虽然有益,但正在进行的研究解决了副作用,成本和长期疗效,以获得最佳的治疗应用.
科学领域:
- 内分泌学 在内分泌学.
- 免疫学 免疫学 免疫学
- 眼科医生 眼科 眼科
背景情况:
- 甲状腺眼病 (TED) 是一种自身免疫性疾病,导致轨道炎症和组织重塑.
- 一种向单克隆抗体的IGF-1R抗体Teprotumumab提供了一种新的治疗方法.
研究的目的:
- 审查teprotumumab在治疗甲状腺眼病中的治疗作用.
- 分析它的作用机制,临床疗效和现实世界的应用.
- 在TED中识别teprotumumab的挑战和未来研究方向.
主要方法:
- 关于teprotumumab的II期和III期临床试验和现实研究的全面审查.
- 对有关IGF-1R/TSHR信号抑制的机制数据的分析.
- 综合关于疗效,安全性,成本和长期结果的证据.
主要成果:
- 德鲁马布在减少亡和改善活跃和慢性TED患者的临床活动得分方面表现出显著的有效性.
- 在各种场景中观察到的临床益处,包括胆固醇视神经病变和耐固醇病例.
- 确定的不良影响包括高血糖和听力障碍,有潜在的种族差异.
结论:
- 泰普穆马布是TED的突破性疗法,有效地准关键的炎症通路.
- 需要进一步的研究来解决与治疗相关的不良影响,与成本相关的可访问性和长期疾病管理.
- 优化teprotumumab的应用需要对其全部治疗潜力和局限性的持续调查.
相关概念视频
Synthesis and Regulation of Thyroid Hormones
5.1K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
5.1K
The Thyroid Gland
4.4K
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
4.4K
Tumor Immunotherapy
664
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
664
Angle Closure Glaucoma: Treatment
691
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
691
Open Angle Glaucoma: Treatment
577
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
577

